Hepatitis B virus surface antigen impairs myeloid dendritic cell function: a possible immune escape mechanism of hepatitis B virus

Immunology

Volumn 126, Issue 2, 2009, Pages 280-289

  Op Den Brouw, Marjoleine L ^a   Binda, Rekha S ^a   Van Roosmalen, Mark H ^c   Protzer, Ulrike ^d   Janssen, Harry L A ^a   Van Der Molen, Renate G ^a,b   Woltman, Andrea M ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b REINIER DE GRAAF HOSPITAL   (Netherlands)

^c BIOMÉRIEUX   (France)

^d INSTITUTE OF EPIDEMIOLOGY   (Germany)

Author keywords

Hepatitis B surface antigen; Myeloid dendritic cells; Tolerance; Viral hepatitis

Indexed keywords

GAMMA INTERFERON; HEPATITIS B SURFACE ANTIGEN; INTERLEUKIN 12;

ANIMAL CELL; ARTICLE; BLOOD; BONE MARROW CELL; CELL DAMAGE; CELL FUNCTION; CELL MATURATION; CELL PROLIFERATION; CELL STIMULATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; DENDRITIC CELL; FEMALE; HEPATITIS B VIRUS; HUMAN; HUMAN CELL; IMMUNE SYSTEM; IMMUNITY; IMMUNOMODULATION; IMMUNOREGULATION; IN VITRO STUDY; INTERNALIZATION; MALE; MOLECULE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; T LYMPHOCYTE; TIME; UPREGULATION; VIRUS PARTICLE;

ADULT; ANTIGENS, CD40; ANTIGENS, CD80; ANTIGENS, CD86; CELLS, CULTURED; DENDRITIC CELLS; FEMALE; HEPATITIS B SURFACE ANTIGENS; HEPATITIS B VIRUS; HUMANS; IMMUNE TOLERANCE; INTERLEUKIN-12; LYMPHOCYTE ACTIVATION; LYMPHOCYTE CULTURE TEST, MIXED; MALE; MIDDLE AGED; T-LYMPHOCYTES; T-LYMPHOCYTES, REGULATORY; UP-REGULATION; VIRUS INTERNALIZATION; YOUNG ADULT;

EID: 58149299723     PISSN: 00192805     EISSN: 13652567     Source Type: Journal    
DOI: 10.1111/j.1365-2567.2008.02896.x     Document Type: Article

References (38)

1. Maini MK, Boni C, Ogg GS et al. Direct ex vivo analysis of hepatitis B virus-specific CD8(+) T cells associated with the control of infection. Gastroenterology 1999 117 : 1386 96.
2. Webster GJ, Reignat S, Maini MK et al. Incubation phase of acute hepatitis B in man: dynamic of cellular immune mechanisms. Hepatology 2000 32 : 1117 24.
3. Marinos G, Torre F, Chokshi S et al. Induction of T-helper cell response to hepatitis B core antigen in chronic hepatitis B: a major factor in activation of the host immune response to the hepatitis B virus. Hepatology 1995 22 : 1040 9.
4. Maini MK, Boni C, Lee CK et al. The role of virus-specific CD8(+) cells in liver damage and viral control during persistent hepatitis B virus infection. J Exp Med 2000 191 : 1269 80.
5. Banchereau J, Steinman RM. Dendritic cells and the control of immunity. Nature 1998 392 : 245 52.
6. Moretta A. Natural killer cells and dendritic cells: rendezvous in abused tissues. Nat Rev Immunol 2002 2 : 957 64.
7. Steinman RM, Hawiger D, Nussenzweig MC. Tolerogenic dendritic cells. Annu Rev Immunol 2003 21 : 685 711.
8. Lanzavecchia A, Sallusto F. Antigen decoding by T lymphocytes: from synapses to fate determination. Nat Immunol 2001 2 : 487 92.
9. van der Molen RG, Sprengers D, Binda RS, de Jong EC, Niesters HG, Kusters JG, Kwekkeboom J, Janssen HL. Functional impairment of myeloid and plasmacytoid dendritic cells of patients with chronic hepatitis B. Hepatology 2004 40 : 738 46.
10. Duan XZ, Zhuang H, Wang M, Li HW, Liu JC, Wang FS. Decreased numbers and impaired function of circulating dendritic cell subsets in patients with chronic hepatitis B infection (R2). J Gastroenterol Hepatol 2005 20 : 234 42.
11. Beckebaum S, Cicinnati VR, Dworacki G et al. Reduction in the circulating pDC1/pDC2 ratio and impaired function of ex vivo-generated DC1 in chronic hepatitis B infection. Clin Immunol 2002 104 : 138 50.
12. Beckebaum S, Cicinnati VR, Zhang X, Ferencik S, Frilling A, Grosse-Wilde H, Broelsch CE, Gerken G. Hepatitis B virus-induced defect of monocyte-derived dendritic cells leads to impaired T helper type 1 response in vitro: mechanisms for viral immune escape. Immunology 2003 109 : 487 95.
13. Tavakoli S, Schwerin W, Rohwer A et al. Phenotype and function of monocyte derived dendritic cells in chronic hepatitis B virus infection. J Gen Virol 2004 85 : 2829 36.
14. Arima S, Akbar SM, Michitaka K, Horiike N, Nuriya H, Kohara M, Onji M. Impaired function of antigen-presenting dendritic cells in patients with chronic hepatitis B: localization of HBV DNA and HBV RNA in blood DC by in situ hybridization. Int J Mol Med 2003 11 : 169 74.
15. Op den Brouw ML, Van Roosmalen MH, Kusters JG, Janssen HLA, van der Molen RG. Functional impairment of mDC in chronic HBV patients: the role of HBV proteins. Abstract. Hepatology 2005 42 : 712A.
16. Untergasser A, Zedler U, Langenkamp A et al. Dendritic cells take up viral antigens but do not support the early steps of hepatitis B virus infection. Hepatology 2006 43 : 539 47.
17. Seeger C, Mason WS. Hepatitis B virus biology. Microbiol Mol Biol Rev 2000 64 : 51 68.
18. Bozdayi AM, Uzunalimoglu O, Turkyilmaz AR et al. YSDD: a novel mutation in HBV DNA polymerase confers clinical resistance to lamivudine. J Viral Hepat 2003 10 : 256 65.
19. Paulij WP, de Wit PL, Sunnen CM, van Roosmalen MH, Petersen-van Ettekoven A, Cooreman MP, Heijtink RA. Localization of a unique hepatitis B virus epitope sheds new light on the structure of hepatitis B virus surface antigen. J Gen Virol 1999 8 : 2121 6.
20. Sells MA, Chen ML, Acs G. Production of hepatitis B virus particles in Hep G2 cells transfected with cloned hepatitis B virus DNA. Proc Natl Acad Sci U S A 1987 84 : 1005 9.
21. Hirschman SZ, Price P, Garfinkel E, Christman J, Acs G. Expression of cloned hepatitis B virus DNA in human cell cultures. Proc Natl Acad Sci U S A 1980 77 : 5507 11.
22. Hori S, Nomura T, Sakaguchi S. Control of regulatory T cell development by the transcription factor Foxp3. Science 2003 299 : 1057 61.
23. van der Molen RG, Sprengers D, Biesta PJ, Kusters JG, Janssen HL. Favorable effect of adefovir on the number and functionality of myeloid dendritic cells of patients with chronic HBV. Hepatology 2006 44 : 907 14.
24. Tavakoli S, Mederacke I, Herzog-Hauff S et al. Peripheral blood dendritic cells are phenotypically and functionally intact in chronic hepatitis B virus (HBV) infection. Clin Exp Immunol 2008 151 : 61 70.
25. Okamoto H, Imai M, Tsuda F, Tanaka T, Miyakawa Y, Mayumi M. Point mutation in the S gene of hepatitis B virus for a d/y or w/r subtypic change in two blood donors carrying a surface antigen of compound subtype adyr or adwr. J Virol 1987 61 : 3030 4.
26. Miyakawa Y, Mizokami M. Classifying hepatitis B virus genotypes. Intervirology 2003 46 : 329 38.
27. Loirat D, Mancini-Bourgine M, Abastado JP, Michel ML. HBsAg/HLA-A2 transgenic mice: a model for T cell tolerance to hepatitis B surface antigen in chronic hepatitis B virus infection. Int Immunol 2003 15 : 1125 36.
28. Vanlandschoot P, Van Houtte F, Roobrouck A, Farhoudi A, Leroux-Roels G. Hepatitis B virus surface antigen suppresses the activation of monocytes through interaction with a serum protein and a monocyte-specific receptor. J Gen Virol 2002 83 : 1281 9.
29. Vanlandschoot P, Roobrouck A, Van Houtte F, Leroux-Roels G. Recombinant HBsAg, an apoptotic-like lipoprotein, interferes with the LPS-induced activation of ERK-1/2 and JNK-1/2 in monocytes. Biochem Biophys Res Commun 2002 297 : 486 91.
30. Stoop JN, van der Molen RG, Baan CC, van der Laan LJ, Kuipers EJ, Kusters JG, Janssen HL. Regulatory T cells contribute to the impaired immune response in patients with chronic hepatitis B virus infection. Hepatology 2005 41 : 771 8.
31. Shimizu Y, Guidotti LG, Fowler P, Chisari FV. Dendritic cell immunization breaks cytotoxic T lymphocyte tolerance in hepatitis B virus transgenic mice. J Immunol 1998 161 : 4520 9.
32. Ma XJ, Tian DY, Xu D, Yang DF, Zhu HF, Liang ZH, Zhang ZG. Uric acid enhances T cell immune responses to hepatitis B surface antigen-pulsed-dendritic cells in mice. World J Gastroenterol 2007 13 : 1060 6.
33. Horiike N, Akbar SMF, Ninomiya T, Abe M, Michitaka K, Onji M. Activation and maturation of antigen-presenting dendritic cells during vaccine therapy in patients with chronic hepatitis due to hepatitis B virus. Hepatol Res 2002 23 : 38 47.
34. Milich DR, Leroux-Roels GG. Immunogenetics of the response to HBsAg vaccination. Autoimmun Rev 2003 2 : 248 57.
35. Reignat S, Webster GJ, Brown D et al. Escaping high viral load exhaustion: CD8 cells with altered tetramer binding in chronic hepatitis B virus infection. J Exp Med 2002 195 : 1089 101.
36. Webster GJ, Reignat S, Brown D et al. Longitudinal analysis of CD8+ T cells specific for structural and nonstructural hepatitis B virus proteins in patients with chronic hepatitis B: implications for immunotherapy. J Virol 2004 78 : 5707 19.
37. Chen M, Sallberg M, Hughes J, Jones J, Guidotti LG, Chisari FV, Billaud JN, Milich DR. Immune tolerance split between hepatitis B virus precore and core proteins. J Virol 2005 79 : 3016 27.
38. Milich D, Liang TJ. Exploring the biological basis of hepatitis B e antigen in hepatitis B virus infection. Hepatology 2003 38 : 1075 86.